
How ML and automation are changing the future of protein therapeutics
Kristen Hopson, Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yue Liu, Associate Director, HTS at Generate Biomedicines, reflect on the impact of artificial intelligence (AI), machine learning (ML), cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research. Proteins are the basic… Read More













